SCHEMBL30656263

SCHEMBL30656263

Cc1ncc(COc2ccc3sc(C)c(C(=O)NC4(CO)CC4)c3c2)s1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
GABRA1 P14867 1/20 0.33
SCN9A Q15858 2/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 3/20 0.32
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32
RAB9A P51151 1/20 0.32
ABL1 P00519 1/20 0.32
BTK Q06187 1/20 0.32
ADAM17 P78536 2/20 0.31
ADAMTS4 O75173 1/20 0.31
MMP3 P08254 1/20 0.31
MMP7 P09237 1/20 0.31
ADAMTS1 Q9UHI8 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.31
CNR2 P34972 3/20 0.31
ICAM1 P05362 1/20 0.31
SELE P16581 1/20 0.31
VCAM1 P19320 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656104 0.96 ABL1 (0.36) L3MBTL1GABRA1RECQLKMT2AABL1
SCHEMBL30656102 0.95 MMP3 (0.38) L3MBTL1GABRA1RECQLKMT2AABL1
SCHEMBL30656220 0.94 L3MBTL1 (0.33) L3MBTL1RECQLKMT2ANPC1POLB
SCHEMBL24484526 0.84 GAA (0.44) L3MBTL1RECQLKMT2APOLBMEN1
SCHEMBL30656205 0.84 EDNRA (0.46) L3MBTL1GABRA1KMT2ANPC1RAB9A
SCHEMBL30656207 0.83 CNR2 (0.38) L3MBTL1ADAM17ADAMTS4MMP3MMP7
SCHEMBL30656075 0.83 L3MBTL1 (0.32) L3MBTL1CNR2
SCHEMBL30656053 0.83 SMO (0.39) KMT2ANPC1RAB9AALDH1A1
SCHEMBL30656026 0.83 SCN9A (0.33) L3MBTL1SCN9AKMT2AADAM17ADAMTS4
SCHEMBL30656261 0.82 CNR2 (0.34) L3MBTL1ADAM17ADAMTS4MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed